Chief of Clinical Pathology Beth Shaz, MD, MBA, was invited by her alma mater, Empire State University, to present at the Women in Business inaugural homecoming event, about the experiences she gained in its Masters of Business Administration program as part of a panel discussion on Sept. 26th, 2024. Pamela Say, MBA, an international consultant, author, journalist, book coach, and the contracted CEO for Orato World Media, was also on the panel.
Moderated by Associate Professor Sylwia Starnawska, PhD, MBA, and Associate Professor Petra Dilling, PhD, MBA, the discussion offered an opportunity for graduates and current students in the Business, Management, and Leadership Division of the School for Graduate Studies to connect. Panelists discussed leadership, success strategies, and answered questions.
“I am incredibly thankful for the diverse group of individuals I met and learned from, both fellow students and the faculty,” said Shaz. “Additionally, I am thankful for a program that offered flexibility allowing me to learn and grow, as well as apply this new knowledge directly to the work I was performing, while working full time and raising a family. Lastly, I also learned about leadership and healthcare policy ̶ areas of interest I maintain today.”
In addition to serving as chief of Clinical Pathology, Shaz is a professor of pathology and deputy director of the Marcus Center for Cellular Cures at Duke University. She’s a member of the Duke Cancer Institute and Margolis Institute for Health Policy, past president of the Association for the Advancement of Blood & Biotherapies (AABB) Board of Directors, and a scientific member of Biomedical Excellence for Safer Transfusion (BEST Collaborative).
She is an expert in transfusion medicine and cellular therapies, with over 20 years of experience. She is co-director of Duke’s Stem Cell Transplant Laboratory and associate director of the Carolinas Cord Blood Bank, one of the largest public cord blood banks in the world.
Shaz has published about 200 peer-reviewed articles and has co-edited eight books. Her main goals are to improve the health of our community and ensure equal access to safe and efficacious blood and biotherapies.
She received her BS in chemical engineering from Cornell University, her MD from the University of Michigan Medical School, and her MBA in healthcare leadership at Empire State University in 2021. She completed her surgical internship at Georgetown University, and her pathology residency and blood banking / transfusion medicine Fellowship at Beth Israel Deaconess Medical Center, Harvard Medical School Harvard Medical School.